Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H21NO4 |
Molecular Weight | 351.3957 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN1C2=C(C=C(OC(C)=O)C=C2)C(C)=C1C3=CC=C(OC(C)=O)C=C3
InChI
InChIKey=KSZGVNZSUJHOJA-UHFFFAOYSA-N
InChI=1S/C21H21NO4/c1-5-22-20-11-10-18(26-15(4)24)12-19(20)13(2)21(22)16-6-8-17(9-7-16)25-14(3)23/h6-12H,5H2,1-4H3
Molecular Formula | C21H21NO4 |
Molecular Weight | 351.3957 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Zindoxifene (D 16726 or 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole), is an antiestrogenic phenylindole with a high affinity for the estrogen receptor. Zindoxifene exerts inhibiting activity against tumors of prostatic and mammary origins both in vitro and in vivo. It was in phase I/II study for the treatment of advanced breast cancer. Zindoxifene development has been discontinued.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2328214
phase I/II study for the treatment of advanced breast cancer: oral zindoxifene doses ranged from 10 to 100 mg daily
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:12:33 GMT 2023
by
admin
on
Sat Dec 16 17:12:33 GMT 2023
|
Record UNII |
1IRS95M8DN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1821
Created by
admin on Sat Dec 16 17:12:33 GMT 2023 , Edited by admin on Sat Dec 16 17:12:33 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000078768
Created by
admin on Sat Dec 16 17:12:33 GMT 2023 , Edited by admin on Sat Dec 16 17:12:33 GMT 2023
|
PRIMARY | |||
|
DTXSID60235396
Created by
admin on Sat Dec 16 17:12:33 GMT 2023 , Edited by admin on Sat Dec 16 17:12:33 GMT 2023
|
PRIMARY | |||
|
C66696
Created by
admin on Sat Dec 16 17:12:33 GMT 2023 , Edited by admin on Sat Dec 16 17:12:33 GMT 2023
|
PRIMARY | |||
|
1IRS95M8DN
Created by
admin on Sat Dec 16 17:12:33 GMT 2023 , Edited by admin on Sat Dec 16 17:12:33 GMT 2023
|
PRIMARY | |||
|
5861
Created by
admin on Sat Dec 16 17:12:33 GMT 2023 , Edited by admin on Sat Dec 16 17:12:33 GMT 2023
|
PRIMARY | |||
|
SUB00163MIG
Created by
admin on Sat Dec 16 17:12:33 GMT 2023 , Edited by admin on Sat Dec 16 17:12:33 GMT 2023
|
PRIMARY | |||
|
CHEMBL32227
Created by
admin on Sat Dec 16 17:12:33 GMT 2023 , Edited by admin on Sat Dec 16 17:12:33 GMT 2023
|
PRIMARY | |||
|
341952
Created by
admin on Sat Dec 16 17:12:33 GMT 2023 , Edited by admin on Sat Dec 16 17:12:33 GMT 2023
|
PRIMARY | |||
|
65645
Created by
admin on Sat Dec 16 17:12:33 GMT 2023 , Edited by admin on Sat Dec 16 17:12:33 GMT 2023
|
PRIMARY | |||
|
86111-26-4
Created by
admin on Sat Dec 16 17:12:33 GMT 2023 , Edited by admin on Sat Dec 16 17:12:33 GMT 2023
|
PRIMARY | |||
|
C041791
Created by
admin on Sat Dec 16 17:12:33 GMT 2023 , Edited by admin on Sat Dec 16 17:12:33 GMT 2023
|
PRIMARY | |||
|
Zindoxifene
Created by
admin on Sat Dec 16 17:12:33 GMT 2023 , Edited by admin on Sat Dec 16 17:12:33 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |